D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model.
about
Application of cross-species PET imaging to assess neurotransmitter release in brainA receptor-based model for dopamine-induced fMRI signal.The role of beta-arrestin2 in shaping fMRI BOLD responses to dopaminergic stimulationHuman biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.Molecular imaging of microglia/macrophages in the brain.Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatmentDeficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction.Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting.Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain.Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI.Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study.Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review.Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging.Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patients.Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors.Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humansThe influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imagingVulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability.PET imaging of dopamine-D2 receptor internalization in schizophrenia.Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.News and views on in-vivo imaging of neurotransmission using PET and MRI.Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2 /D3 dopamine system.Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.Effect of mazindol on extracellular dopamine concentration in human brain measured by PET.
P2860
Q26865012-264D0B34-A80B-4F22-A3B6-B9AD91D82FA1Q30434854-2CBA92B8-0D63-49D5-A8D5-728C9C84DBB6Q33841893-24BB4009-EA27-4D34-92E2-6D91190C7166Q34043059-19A542A5-575F-4D13-B353-AD558D55AFFAQ34276818-853F7546-BA2D-49A2-80F3-13A0ACB79079Q35607225-E7CAEE8B-C394-49C3-947E-E85951A2182AQ35661488-E48FF039-C516-47CD-99EA-E7845F44C50CQ35882042-889F9E13-8391-4000-AF3E-64B0C51BDD3EQ36206973-13700DAC-E60E-4DF3-9298-ADD3CC0C0B79Q36524516-16B06AEB-B2AB-4947-A4E6-0C6442CBA3A0Q36690726-325BD956-4604-4DCA-AEC4-527BE2A13F4DQ36723314-9FC24097-27DE-45B6-A781-FC5C35808D35Q36894509-5A162B1A-8DC8-4CC4-B3BE-2FC62915D74EQ36997098-B3DE38E1-63AA-46F8-ABE8-273FA4BF617EQ37776154-1FFA8086-AE0F-493F-8B54-3FA22F881004Q37825633-DF0632EC-12AB-4D81-AD9B-E4D2E98495B1Q37838858-7AA60F3E-A457-4FD7-BF00-482101461DBCQ37871233-44F8BB37-765B-488D-9DC4-A322E0C485B8Q38065991-AF50E7A8-CFAF-4648-A360-084DA9772580Q38611990-051D7E17-7A79-4AF3-A2A9-23AA5A3F2D6EQ40379505-2FA9B770-804E-4E8B-8283-F5B7BA0EF887Q42551362-01483E4F-FE5E-4902-B06F-0BC78A164058Q42745975-13A381F3-860C-40DD-9FDC-6222225C4529Q44510576-18A44700-22EE-4C30-B0B6-D0570C0497EBQ47128397-DB8D86F2-F8DA-463F-9900-28CDFEED260DQ48102225-88140646-EB07-40C1-BF7B-28BC71654E0CQ48176913-23FD6136-7C84-4025-9840-8EB68B7812B5Q48631545-E8D0E0EF-ECBE-48F7-8F30-4A7858C44324Q48875088-E2A87AB6-E71D-43B6-B722-39CAE6D7B4A2Q52303822-FE50CED4-9A38-450F-BB8A-37997D2AA8FD
P2860
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
D2 dopamine receptor internali ...... ization-deficient mouse model.
@ast
D2 dopamine receptor internali ...... ization-deficient mouse model.
@en
type
label
D2 dopamine receptor internali ...... ization-deficient mouse model.
@ast
D2 dopamine receptor internali ...... ization-deficient mouse model.
@en
prefLabel
D2 dopamine receptor internali ...... ization-deficient mouse model.
@ast
D2 dopamine receptor internali ...... ization-deficient mouse model.
@en
P2093
P2860
P50
P1433
P1476
D2 dopamine receptor internali ...... ization-deficient mouse model.
@en
P2093
David R Sibley
Jeih-San Liow
Jinsoo Hong
Mette Skinbjerg
Nicholas Seneca
Robert B Innis
Victor W Pike
P2860
P304
P356
10.1016/J.NEUROIMAGE.2010.01.055
P407
P577
2010-01-22T00:00:00Z